Skip to content

The effect of appendectomy on the clinical course of Ulcerative colitis: a randomized multicenter trial

The effect of appendectomy on the clinical course of Ulcerative colitis: a randomized multicenter trial - ACCURE trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON53054
Enrollment
154
Registered
2011-11-03
Start date
2012-09-20
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammatory bowel disease Ulcerative colitis

Interventions

Patients will be randomized to laparoscopic appendectomy or to no appendectomy in day care setting.

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - Aged 18 years and older - Established diagnosis of ulcerative colitis (any extent of disease) - Disease relapse within 12 months of randomisation medically treated until remission - Clinical (Mayo score

Exclusion criteria

Exclusion criteria: - Prior appendectomy or other major abdominal surgery precluding safe appendectomy - Any suspicion of Crohn's disease - Disease recently treated with biologicals within 3 months prior to inclusion - Severe disease ever treated with biologicals and stopped due to secondary non-response - Toxic megacolon or severe ongoing colitis at time of randomimsation - Patients with active extra-intestinal infections, liver or kidney failure, mayor lung and heart co-morbidity. - Insufficient command of Dutch or cognitively unable to complete Dutch questionnaires

Design outcomes

Primary

MeasureTime frame
1. The one year UC relapse rate (defined both clinically and endoscopically as Mayo-score >=5 with endoscopy score of 2 or 3).

Secondary

MeasureTime frame
1. Number of relapses per patient 2. Time to first relapse. 3. Health related quality of life (EQ-5D, EORTC-QLQ-C30-QL, IBDQ and a 'global change question'). 4. Disease activity, as measured with fecal calprotectin and the Mayo score. 5. Number of colectomies

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)